Recital 138, Commission Decision of 12/12/2023 declaring a concentration to be compatible with the co…

In forcesince 12 Dec 2023

First, the Parties consider that post-Transaction the merged entity will not have

significant market power based on the relatively low market shares and nonproblematic increment.

208 The Parties submit that post-Transaction, the merged entity will continue to face strong competitors who will impose significant competitive constraints. The Parties mention DSM (considered as a clear segment leader), IFF and a large number of distributors active in the distribution of lactase.209